Author:
Linscott Joshua A.,Miyagi Hiroko,Murthy Prithvi B.,Yao Sijie,Grass G. Daniel,Vosoughi Aram,Xu Hongzhi,Wang Xuefeng,Yu Xiaoqing,Yu Alice,Zemp Logan,Gilbert Scott M.,Poch Michael A.,Sexton Wade J.,Spiess Philippe E.,Li Roger
Publisher
Springer Science and Business Media LLC
Reference122 articles.
1. Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14:531–48.
2. Cisneros-Villanueva M, Hidalgo-Pérez L, Rios-Romero M, Cedro-Tanda A, Ruiz-Villavicencio CA, Page K, et al. Cell-free DNA analysis in current cancer clinical trials: a review. Br J Cancer. 2022;126:391–400.
3. Chaudhuri AA, Pellini B, Pejovic N, Chauhan PS, Harris PK, Szymanski JJ, et al. Emerging roles of urine-based tumor DNA analysis in bladder cancer management. JCO Precis Oncol. 2020;4:PO.20.00060.
4. Rose KM, Huelster HL, Meeks JJ, Faltas BM, Sonpavde GP, Lerner SP, et al. Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease. Nat Rev Urol. 2023;20:406–19.
5. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.